State of Tennessee, Department of Treasury’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Sell
23,297
-229
-1% -$20.3K 0.01% 830
2025
Q4
$1.92M Sell
23,526
-2,964
-11% -$243K 0.01% 951
2025
Q3
$1.76M Buy
26,490
+500
+2% +$28.4K 0.01% 984
2025
Q2
$1.44M Sell
25,990
-495
-2% -$23.8K 0.01% 1021
2025
Q1
$1.28M Sell
26,485
-591
-2% -$24.8K ﹤0.01% 1061
2024
Q4
$1.05M Sell
27,076
-667
-2% -$29.1K ﹤0.01% 1184
2024
Q3
$1.25M Buy
+27,743
New +$1.12M ﹤0.01% 1126

Other funds holding PTGX

State of Tennessee, Department of Treasury's PTGX Position: Q1 2026 in Review

State of Tennessee, Department of Treasury reduced its Protagonist Therapeutics (PTGX) stake by 0.97% in Q1 2026, selling an estimated $20.3K and leaving 23,297 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #830.

State of Tennessee, Department of Treasury first reported a position in PTGX in Q3 2024 and has held it in 7 quarters since. 319 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • State of Tennessee, Department of Treasury held 23,297 shares of Protagonist Therapeutics worth $2.46M as of Q1 2026.
  • State of Tennessee, Department of Treasury sold 229 Protagonist Therapeutics shares in Q1 2026, an estimated $20.3K.
  • Protagonist Therapeutics made up 0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #830 holding.
  • State of Tennessee, Department of Treasury first reported a position in Protagonist Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 319 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.